This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1962:203:560-74.

doi: 10.1007/BF00343235.

[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis]

[Article in German]

W BIRKMAYER, O HORNYKIEWICZ

PMID: 13971142
DOI: 10.1007/BF00343235

[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis]

[Article in German]

W BIRKMAYER et al. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr. 1962.

. 1962:203:560-74.

doi: 10.1007/BF00343235.

Authors

W BIRKMAYER, O HORNYKIEWICZ

PMID: 13971142
DOI: 10.1007/BF00343235

No abstract available

PubMed Disclaimer

Similar articles

[Features of medical therapy of Parkinson's syndrome].
BIRKMAYER W, MENTASTI M. BIRKMAYER W, et al. Wien Klin Wochenschr. 1962 Oct 12;74:700-2. Wien Klin Wochenschr. 1962. PMID: 13971141 German. No abstract available.
[On the treatment of Parkinson's syndrome with monoamine oxidase inhibitors alone and in combination with L-dopa].
Gerstenbrand F, Prosenz P. Gerstenbrand F, et al. Praxis. 1965 Nov 18;54(46):1373-7. Praxis. 1965. PMID: 5899418 German. No abstract available.
[The trial of intravenous L-DOPA in patients with Parkinson's disease].
Nardini M, Fieschi C, Agnoli A, Arcioli I, Zanette E. Nardini M, et al. Riv Neurol. 1970 Mar-Apr;40(2):75-85. Riv Neurol. 1970. PMID: 5429003 Clinical Trial. Italian. No abstract available.
[l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
Degkwitz R. Degkwitz R. Med Klin. 1969 Aug 15;64(33):1451-6. Med Klin. 1969. PMID: 4896563 Review. German. No abstract available.
[Parkinson's disease: current therapeutic aspects].
Casati C. Casati C. Clin Ter. 1971 Jan 15;56(1):71-9. Clin Ter. 1971. PMID: 4944741 Review. Italian. No abstract available.

See all similar articles

Cited by

[AUTONOMIC REGULATION DISTURBANCES IN PATIENTS RECOVERING FROM ENCEPHALITIS].
BIRKMAYER W. BIRKMAYER W. Acta Neuroveg (Wien). 1964 Oct 2;26:544-51. doi: 10.1007/BF01252150. Acta Neuroveg (Wien). 1964. PMID: 14317359 German. No abstract available.
MAO-inhibitors in Parkinson's Disease.
Riederer P, Laux G. Riederer P, et al. Exp Neurobiol. 2011 Mar;20(1):1-17. doi: 10.5607/en.2011.20.1.1. Epub 2011 Mar 31. Exp Neurobiol. 2011. PMID: 22110357 Free PMC article.
Neurochemical bases of tremor and other disorders of movement.
Sourkes TL, Poirier LJ. Sourkes TL, et al. Can Med Assoc J. 1966 Jan 8;94(2):53-60. Can Med Assoc J. 1966. PMID: 4380339 Free PMC article.
Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs.
Charvin D, Medori R, Hauser RA, Rascol O. Charvin D, et al. Nat Rev Drug Discov. 2018 Nov;17(11):804-822. doi: 10.1038/nrd.2018.136. Epub 2018 Sep 28. Nat Rev Drug Discov. 2018. PMID: 30262889 Review.
Functional dopamine D2 receptors on rat vagal afferent neurones.
Lawrence AJ, Krstew E, Jarrott B. Lawrence AJ, et al. Br J Pharmacol. 1995 Apr;114(7):1329-34. doi: 10.1111/j.1476-5381.1995.tb13352.x. Br J Pharmacol. 1995. PMID: 7606337 Free PMC article.

See all "Cited by" articles

References

1. Experientia. 1959 Jan 15;15(1):10-1 - PubMed
1. JAMA. 1961 Sep 9;177:665-70 - PubMed
1. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;234(3):194-205 - PubMed
1. Science. 1961 May 26;133(3465):1706-7 - PubMed
1. Arch Biochem Biophys. 1961 May;93:338-43 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database